Intracoronary Stenting and Antithrombotic Regimen: ADjusting Antiplatelet Treatment in PatienTs Based on Platelet Function Testing

NCT01456364 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Coronary Heart Disease

Interventions

DRUG: Ticagrelor
DRUG: Prasugrel

Sponsor

Deutsches Herzzentrum Muenchen